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Abstract Epigenetic inheritance (EI) of metabolic phe-
notypes via the paternal lineage has been shown in rodent
models of diet-induced obesity (DIO). However, the factors
involved in soma-to-germline information transfer remain
elusive. Here, we address the role of alterations in insulin,
leptin, and adiponectin levels for EI of metabolic pheno-
types by treating C57BL/6NTac male mice (F0) with the
synthetic glucocorticoid dexamethasone and generating
offspring (F1) either by in vitro fertilization or by natural
fecundation. Dexamethasone treatment slightly alters F0
body composition by increasing fat mass and decreasing
lean mass, and significantly improves glucose tolerance.
Moreover, it increases insulin and leptin levels and reduces
adiponectin levels in F0 fathers as observed in mouse
models of DIO. However, these paternal changes of
metabolic hormones do not alter metabolic parameters,
such as body weight, body composition and glucose
homeostasis in male and female F1 mice even when these
are challenged with a high-fat diet. Accordingly, sperm
transcriptomes are not altered by dexamethasone treatment.
Our results suggest that neither increased glucocorticoid,
insulin, and leptin levels, nor decreased adiponectin levels
in fathers are sufficient to confer soma-to-germline infor-
mation transfer in EI of obesity via the paternal lineage.
Introduction
In the past decades, metabolic disorders (MDs) such as
obesity, metabolic syndrome (MetS), and type 2 diabetes
(T2D) became worldwide epidemics with continuously
rising prevalence (Farag and Gaballa 2011; Kaur 2014).
This development is mainly due to an increasing imbalance
of energy intake and expenditure caused by changed
environmental factors such as the growing availability of
high-caloric diets and a sedentary lifestyle (Farag and
Gaballa 2011; Kaur 2014). However, MDs also have a
heritable component. Although many genetic variants that
are linked to MDs have been identified, they commonly
have small effect sizes and explain only a small percentage
of heritability. For example, about 70 loci identified by
genome-wide association studies (GWAS) account for only
about 10 % of the heritability of T2D [reviewed in (Hara
et al. 2014; Hirschhorn and Gajdos 2011)]. Also, a recent
GWAS using body mass index (BMI) as a measure for
obesity reported 97 loci that account for only 2.7 % of BMI
phenotypic variation (Locke et al. 2015). The list of com-
mon and rare genetic variants that contribute to MD sus-
ceptibility is not complete, yet it is highly unlikely that
genetic drift significantly contributed to the epidemic
spread of diabetes in the past few decades (Stoger 2008).
Instead, epidemiological and experimental studies point
Electronic supplementary material The online version of this
article (doi:10.1007/s00335-015-9616-5) contains supplementary
material, which is available to authorized users.
& Johannes Beckers
beckers@helmholtz-muenchen.de
1 Institute of Experimental Genetics and German Mouse
Clinic, Helmholtz Zentrum Mu¨nchen GmbH - German
Research Center for Environmental Health, Ingolsta¨dter
Landstr. 1, 85764 Neuherberg, Germany
2 Institute of Pathology, Helmholtz Zentrum Mu¨nchen GmbH -
German Research Center for Environmental Health,
85764 Neuherberg, Germany
3 Chair of Experimental Genetics, Technische Universita¨t
Mu¨nchen, 85354 Freising, Germany
4 German Center for Diabetes Research (DZD),
85764 Neuherberg, Germany
123
Mamm Genome (2016) 27:17–28
DOI 10.1007/s00335-015-9616-5
toward epigenetic inheritance (EI) as an important contri-
bution to the observed epidemic spread of MDs (Desai
et al. 2015; Rando and Simmons 2015; Somer and
Thummel 2014; Stoger 2008; Szyf 2015). Importantly, EI
could propagate responses to environmental stimuli much
faster than genetic drift (Jablonka and Raz 2009).
Animal studies provided evidence for the contribution of
both parents to EI. However, contribution from the
maternal lineage is difficult to correlate to germline alter-
ations due to the altered in utero environment during
pregnancy and the close interaction between mother and
offspring during lactation, which also affect the offspring’s
metabolic status (Desai et al. 2015; Rando and Simmons
2015; Williams et al. 2014). Therefore, especially the
contribution of the paternal lineage was in the focus in
recent epigenetic studies as it is more confined to the
germline. Studies in rodent models have shown that
paternal diet-induced obesity (DIO) leads to alterations in
body weight and glucose metabolism in the offspring
(Fullston et al. 2013; Ng et al. 2010, 2014; Wei et al. 2014).
Some of the studies also provided initial evidence for
alterations in sperm that could explain the offspring´s phe-
notype, including changes in DNA methylation and
miRNA content (Fullston et al. 2013; Ng et al. 2010; Wei
et al. 2014). However, the mechanisms by which the
paternal diet leads to germline alterations remain elusive,
but a variety of possible triggers of soma-to-germline
information transfer have been proposed. These include, in
particular, inflammation (Fullston et al. 2013), hormones,
and circulating RNAs (Jablonka and Raz 2009; Sharma
2013; Szyf 2015). Recently, one seminal study on the EI of
altered hepatic wound-healing response provided evidence
for the key role of factors present in plasma for the pro-
gramming of epigenetic patterns in sperm (Zeybel et al.
2012); however, specific paternal factors were not
identified.
In obese and pre-diabetic humans as well as in DIO
animal models, plasma factors, including several hor-
mones, are altered. Elevated levels of insulin (hyperinsu-
linemia) and leptin (hyperleptinemia) have been reported
(Bluher 2014; Fullston et al. 2013; Kaur 2014; Ng et al.
2010; Rabe et al. 2008; Shimizu et al. 2007; Slieker et al.
1996; Wei et al. 2014). In addition, adiponectin levels are
reduced (Bluher 2014; Kaur 2014), resulting in an
increased leptin/adiponectin ratio, which serves as a robust
biomarker for the metabolic syndrome (Falahi et al. 2013;
Satoh et al. 2004). Importantly, the receptors for all three
hormones are expressed in testis (Ahn et al. 2013;
Ramachandran et al. 2013; Zamorano et al. 1997), pro-
viding a potential role of these hormones in soma-to-
germline information transfer. Moreover, leptin receptor
and proteins of the insulin signaling pathway are also
expressed in sperm (Wang et al. 2013), potentially enabling
direct signaling of both insulin and leptin to male gametes.
Besides spermatozoa, semen also consists of seminal fluid-
containing various factors important for fertilization,
including hormones and cytokines. The potential involve-
ment of seminal fluid in EI has been discussed (Bromfield
2014; Rando 2012) and, only recently, the absence of
seminal fluid during mating has been shown to cause
obesity and glucose intolerance in male offspring (Brom-
field et al. 2014). This is consistent with the notion that
alterations in seminal fluid contribute to non-genetic
inheritance of metabolic phenotypes. Interestingly, adipo-
nectin (Heinz et al. 2015), insulin, and leptin (Binder et al.
2015) are all present in seminal fluid. Moreover, the levels
of insulin and leptin are increased in obese mice (Binder
et al. 2015), making these hormones potential carriers of
non-genetic intergenerational information by a mechanism
independent of sperm.
In this study, we established a mouse model to address
the role of the hormones insulin, leptin, and adiponectin for
the intergenerational EI of metabolic phenotypes in the
absence of obesity and most of its associated complica-
tions, such as low grade inflammation. Focusing on
paternal contribution, we treated C57BL/6NTac male mice
with dexamethasone, a synthetic glucocorticoid previously
shown to increase insulin (Rafacho et al. 2014) and leptin
(Slieker et al. 1996) levels and to decrease adiponectin
levels (Fasshauer et al. 2002). We analyzed offspring
generated via either in vitro fertilization (IVF) or natural
matings with regard to obesity and glucose metabolism.
The findings presented here make insulin, leptin, and adi-
ponectin unlikely to be the major factors for EI reported in
DIO rodent models before (Fullston et al. 2013; Ng et al.
2010, 2014; Wei et al. 2014). Accordingly, transcriptome
analyses of sperm from dexamethasone-treated mice did
not show significant alterations in gene regulation com-
pared to control mice.
Materials and methods
Animals and diets
All mice (C57BL/6NTac) were housed under standard
conditions (12:12 h light–dark cycle, light phase:
06:00–18:00 h). All animals of the F0 generation were fed
a standard chow diet (Diet #1310, Altromin, Germany). All
animals of the F1 generation were fed a standard chow diet
until they were challenged with high-fat research diet
(HFD) with 60 % energy from fat (EF R/M D12492 mod.,
Ssniff, Germany) starting at 9 weeks of age. All animal
experiments were approved by the authorities of Upper
Bavaria (Regierung von Oberbayern).
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Dexamethasone treatment (F0 generation)
and phenotypic characterization
Starting at 9 weeks of age, male mice (F0) were either
treated with dexamethasone (Dex) at a concentration of
2 mg/kg body weight (D4902, Sigma-Aldrich, USA) dis-
solved in (2-Hydroxypropyl)-b-cyclodextrin solution
(H5784, Sigma-Aldrich, USA) at 10 mg/ml and further
diluted 50-fold in sterile saline (final dexamethasone con-
centration 0.2 mg/ml) or were treated with vehicle (Veh),
(2-Hydroxypropyl)-b-cyclodextrin solution 50-fold diluted
in sterile saline. Every mouse received a total of 15
injections within 33 days (always on Monday, Wednesday,
and Friday). During the treatment, body weight and blood
glucose were measured once a week at 14:00 h after 6 h
fasting. Body composition (MiniSpec LF50, Bruker Optics,
Germany) was measured on the last day of the treatment
(before the injection), and an intraperitoneal (ip) glucose
tolerance test (GTT; 2 g/kg body weight glucose, Braun,
Germany) was conducted 1 day after the treatment at
14:00 h (6 h fasted).
After 1 week of rest, animals were either mated with
untreated females or sacrificed to collect organs and sperm,
used either for in vitro fertilization (IVF) or for transcrip-
tome analyses. In total, 19 males (9 Veh, 10 Dex) were
used to generate offspring; 3 Veh versus 3 Dex was used in
IVF; 6 Veh versus 7 Dex went into natural matings. For
natural matings, every male was mated three times with
two females, each time from Monday morning to Friday
afternoon and single housed in between matings. For the F1
generation, starting with the beginning of the HFD chal-
lenge at 9 weeks of age, body weight and blood glucose
were measured. Body composition was measured after
6 weeks of HFD challenge and an ipGTT was conducted
after 7 weeks of HFD challenge. A scheme of the experi-
mental layout is shown in Fig. 1.
Plasma hormone levels and assessment of insulin
resistance (HOMA-IR)
Directly before the start of the ipGTT at 14:00 h (6 h
fasted), blood was collected from the tail tip into EDTA-
coated tubes, centrifuged for 5 min at 17009g (10 C), and
plasma aliquots were frozen in liquid nitrogen. Insulin and
leptin were measured in parallel using the Mouse Meta-
bolic Kit (MSD, USA) and adiponectin was measured
using the Mouse Adiponectin Kit (MSD, USA) according
to the manufacturer’s protocol.
Insulin resistance was determined by homeostatic model
assessment-insulin resistance (HOMA-IR) and was calcu-
lated by using fasting glucose and insulin levels from
measurements just before the start of the ipGTT by the
following formula: HOMA-IR = glucose (mg/dl) 9 in-
sulin (lU/ml)/405.
Statistical analyses of phenotypic data
Time course data (body weight, blood glucose, and ipGTT)
were analyzed by repeated measures two-way ANOVA
(rANOVA). Weaning weights, areas under the curve
(AUC) of ipGTTs as well as hormone measurements and
HOMA-IR values were analyzed by t tests (unpaired,
homoscedastic, two-tailed). If variances were significantly
different between groups, t tests with Welch’s correction
were performed. In all figures and in the text, the mean and
standard deviation are given. Differences in body compo-
sition were addressed by analysis of covariance
(ANCOVA), fat and lean mass were adjusted to the mean
body weight of the (paternal) treatment group followed by
t tests as described (Seyfarth et al. 2015). In all statistical
tests, a p value below 0.05 was considered statistically
significant. All analyses were performed using GraphPad
Prism version 6.00 for Windows, GraphPad Software, La
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Fig. 1 Study design. To analyze the role of insulin, leptin, and
adiponectin levels in EI of metabolic phenotypes, we treated C57BL/
6NTac male mice (F0) for 5 weeks with dexamethasone, starting at
9 weeks of age. Animals were tested for metabolic parameters as
indicated (body weight, fasting blood glucose, hormone levels, body
composition, and ipGTT). After 1 week of rest, sperm was obtained
to generate offspring (F1) by IVF using oocytes from untreated
C57BL/6NTac mice and transferring embryos into CD-1 foster
mothers. Alternatively, males were mated with untreated C57BL/
6NTac females. Male and female mice of the F1 generation were
challenged with HFD starting at 9 weeks of age and metabolically
analyzed as indicated
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Double immunohistochemistry
Pancreata were fixed in neutral-buffered formalin for at
least 24 h, embedded in paraffin, and cut in 1 lm sections
for immunohistochemistry. Slides were stained by Roche-
VENTANA Discovery XT automated slide stainer
according to the company’s protocol. The following pri-
mary antibodies were used: polyclonal rabbit anti-human
glucagon (1:1500; A0565, Dako) visualized by DAB (3,30-
diaminobenzidine) and polyclonal guinea pig anti-porcine
insulin (1:750; A0564, Dako) stained with Fast Red. Heat
antigen retrieval was followed by pretreatment of slides in
Cell Conditioning Solution (CC1 mild, Ventana, Roche).
Counterstaining was done with hematoxylin. All sections
were interpreted independently by two pathologists.
Liver histology
For Oil-Red-O histochemistry liver samples were fixed in
Baker’s formol calcium to preserve phospholipids. Tissue
were frozen (-14 C) and cut into 5 lm sections, rinsed
with 60 % isopropanol, stained with freshly prepared Oil-
Red-O (Merck Millipore, Cat. 105230) working solution
for 10 min, and rinsed again in 60 % isopropanol. Coun-
terstaining was performed with Mayer’s acid hemalaun and
mounted with glycerol gelatin (Merck Millipore, Cat.
109242). All sections were independently evaluated by two
expert pathologists.
In vitro fertilization (IVF)
For the generation of the F1 generation by IVF, sperm was
obtained from a total of three males per group (Dex, Veh)
from the F0 generation. Oocyteswere obtained fromC57BL/
6NTac mice, and embryos were transferred into CD-1 foster
mothers. Sperm and oocyte isolation as well as IVF were
conducted following standardized procedures described on
the INFRAFRONTIER homepage. The whole procedure
was carried out on three independent experimental days
(always one male per group and experimental day).
Sperm isolation for transcriptome analyses (F0
generation)
Sperm samples were collected after isoflurane anesthesia
using the swim-up method as described (Brykczynska et al.
2010) with slight modifications. Briefly, dissected cauda
epididymides from both sides were transferred into sperm
motility medium (135 mM NaCl, 5 mM KCl, 1 mM
MgSO4, 2 mM CaCl2, 30 mM Hepes pH 7.4; freshly
supplemented with 10 mM lactate acid, 1 mM sodium
pyruvate, 20 mg/ml BSA, and 25 mM NaHCO3), cut sev-
eral times, and incubated at 37 C for at least 20 min. The
supernatant containing mature motile sperm was carefully
removed and transferred into a new tube. To increase the
yield, fresh sperm motility medium was added to the
original tube (containing the epididymis and sperm), the
tube was inverted to gently mix the sample, and cen-
trifuged at 10009g for 1 min. Afterward, the sample was
again incubated at 37 C for at least 20 min to allow motile
sperm to swim to the surface, and the supernatant was
carefully removed. The supernatants of both incubations
were combined and centrifuged at 10,0009g for 1 min at
4 C. The sperm pellet was frozen in liquid nitrogen.
RNA isolation and transcriptome analyses
For RNA isolation, sperm samples were thawed on ice,
washed 3 times with 500 ll phosphate-buffered saline
(PBS) (centrifuged at 10009g for 2 min, 4 C in between
washes), and the complete RNA was isolated using the
miRNeasy Mini kit (Qiagen, Germany). The quality of the
RNA was analyzed on the Bioanalyzer using the RNA
6000 pico Kit (Agilent, USA). Total RNA (about 10 ng)
was amplified using the Ovation PicoSL WTA System V2
in combination with the Encore Biotin Module (Nugen).
Amplified cDNA was hybridized on Affymetrix Mouse
Gene 2.0 ST arrays containing about 34,000 probe sets.
Staining and scanning (Scanner 3000 7G) were done
according to the Affymetrix gene expression protocol
including minor modifications as suggested in the Encore
Biotin protocol.
Expression console (v.1.4.0.38, Affymetrix) was used
for quality control and to obtain annotated normalized
Robust Multi-array Average (RMA) gene-level data
(standard settings including median polish and sketch-
quantile normalization). Statistical analyses were per-
formed by utilizing the statistical programming environ-
ment R (R Core Team 2014) implemented in CARMAweb
(Rainer et al. 2006). Genewise testing for differential
expression was done employing the limma t test and
Benjamini-Hochberg multiple testing correction
(FDR\ 10 %). The cluster dendrogram was generated
with the R script hclust. Array data have been submitted to
GEO (GSE67290).
Results
To test the hypothesis that altered plasma levels of insulin,
leptin, and adiponectin are causative for EI of metabolic
disorders in DIO models (Fullston et al. 2013; Ng et al.
2010, 2014; Wei et al. 2014), we induced such hormonal
changes in the absence of obesity and most of its compli-
cation in F0 male mice by administration of dexametha-
sone. To focus on those hormonal changes in lean mice, we
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kept the F0 males on standard diet. The time frame from
the start of the dexamethasone treatment to the start of the
matings or sperm isolation was chosen to encompass the
duration of more than one full cycle of spermatogenesis
(40 days) (Adler 1996). This procedure ensured exposure
of sperm to altered hormonal levels throughout spermato-
genesis (Fig. 1).
Effects of dexamethasone treatment in the F0
generation
Chronic dexamethasone treatment alters body composition
Chronically elevated glucocorticoid levels in humans lead
to central obesity in conjunction with a reduction of lean
mass due to muscle atrophy (Kaur 2014; Vegiopoulos and
Herzig 2007). To test whether we find similar alterations in
our mouse model, we measured body weight during the
course of the treatment and body composition at its end, at
the age of 14 weeks. Although we did not detect any dif-
ferences in body weight gain between the two groups
(Fig. 2a), we found both a small but significant increase in
fat mass (Fig. 2c, d) and a respective loss in lean mass in
dexamethasone-treated male mice (Fig. 2e, f) in agreement
with recent findings in a similar mouse model (Hochberg
et al. 2015). Importantly, this increase in fat mass is more
than one order of magnitude smaller than changes observed
in BL6 mice on HFD [increase of about 0.5 g of adjusted
fat mass in Dex F0 (Fig. 2d) as compared to an increase of
more than 6 g of adjusted fat mass in HFD-fed F1 males
(Supplementary Fig. 3B)]. Hence, although body compo-
sition is slightly altered, dexamethasone-treated male mice
on standard diet are far from being obese.
Chronic dexamethasone treatment lowers blood glucose
levels and improves glucose tolerance
Another hallmark of chronically elevated glucocorticoid
levels are changes in glucose metabolism due to insulin
resistance (IR) induced by glucocorticoid signaling in vari-
ous tissues (Rafacho et al. 2014; Vegiopoulos and Herzig
2007). We measured fasting blood glucose concentrations
during the course of the treatment and tested glucose toler-
ance at the end of the treatment. Surprisingly, and in contrast
to most studies, we found a slight decrease in fasting blood
glucose levels (Fig. 2b) as well as an increase in glucose
tolerance following chronic dexamethasone treatment. In
dexamethasone-treated male mice, the area under the curve
(AUC) during ipGTTwas reduced by approximately 25 % in
comparison to vehicle-treated animals (Fig. 2g, h). In line
with this finding, a recent study performed in rhesus maca-
ques also reported strongly improved glucose tolerance
following chronic dexamethasone treatment with a 50 %
reduction of postprandial AUC (Cummings et al. 2013)
presumably due to changes in blood insulin levels (see
below).
Dexamethasone treatment recapitulates increases
in insulin and leptin levels observed in DIO mouse models
of EI
To confirm that our mouse model exhibits hormonal
changes as those seen in obesity and MetS, we measured
plasma levels of relevant hormones at the end of the dex-
amethasone treatment. Strikingly, in the dexamethasone-
treated animals, both insulin (about 1.7-fold) and leptin
(about 2.6-fold) were increased, whereas adiponectin was
slightly decreased (about 0.86-fold) in comparison to
vehicle-treated mice (Fig. 3a). Importantly, the leptin/adi-
ponectin ratio was increased about threefold in the com-
parison of dexamethasone versus vehicle-treated male mice
(Fig. 3a).
In C57BL/6NTac male mice, dexamethasone treatment
induced only modest IR with a 1.6-fold increase in HOMA-
IR (Fig. 3b), in line with an increase in liver fat content
(Fig. 3d), which might explain the improved glucose tol-
erance that we observed (Fig. 2g, h). As glucose tolerance
is influenced by both peripheral insulin sensitivity and
blood insulin concentration, modest IR does not necessarily
result in glucose intolerance if insulin levels increase
accordingly. Thus, although being modestly insulin resis-
tant (Fig. 3b), the significantly elevated insulin levels
before and during ipGTT (Fig. 3a, c) in dexamethasone-
treated male mice most likely over-compensate the glu-
cocorticoid-induced IR. A similar overcompensation of IR
by an altered hormonal response was also reported in the
recent study in rhesus macaques mentioned above (Cum-
mings et al. 2013), providing another example that hor-
monal adjustments can indeed be stronger than the relative
resistance to them that is induced by dexamethasone
treatment. Furthermore, as a result of dexamethasone
treatment, pancreatic islets were increased in size, conflu-
ent and irregularly shaped (Supplementary Fig. S1) as
reported in other rodent models [reviewed in (Rafacho
et al. 2014)].
Taken together, the mouse model presented here
specifically recapitulates key hormonal alterations of
human obesity and MetS as well as DIO in mice. Impor-
tantly, the fold changes in insulin and leptin levels in our
mouse model are in the same range as those in DIO mouse
models of EI of metabolic phenotypes (Fullston et al. 2013;
Wei et al. 2014), showing the validity of our approach to
alter those hormone levels in the absence of obesity.
Unfortunately, changes in adiponectin levels have not been
addressed in the studies cited above.
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Fig. 2 Chronic dexamethasone treatment alters body composition
and glucose metabolism. C57BL/6NTac male mice were treated with
2 mg/kg dexamethasone (Dex: n = 18) or vehicle solution (Veh:
n = 16). No body weight changes due to dexamethasone treatment
were observed (a) but blood glucose levels were slightly reduced (b:
rANOVA, p = 0.0026). Body composition was different at the end of
the treatment with an increase in fat mass (c, d: p = 0.0141), and a
decrease in lean mass (e, f: p = 0.0169) in the dexamethasone-treated
group (d, f: ANCOVA analysis: fat mass and lean mass were adjusted
to the mean body mass of the respective treatment group). Dexam-
ethasone treatment improved glucose tolerance in ipGTT (G:
rANOVA, p\ 0.001; H: t test: p\ 0.001, AUC: area under the
curve). Mean ± standard deviation (a, b, d, f–h) or least square
regression lines (c, e) are shown
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Effects of paternal dexamethasone treatment
in the F1 generation
Paternal dexamethasone treatment does not influence
metabolic parameters in the offspring via sperm
In order to unequivocally relate potential metabolic phe-
notypes in the offspring to epigenetic modifications present
in sperm, we chose to generate offspring via IVF. The
social interaction between male and female mice during the
mating can cause a phenotype in the F1 generation via a
mechanism called paternally induced maternal care (Curley
et al. 2011; Mashoodh et al. 2012; Rando 2012). Here, the
female judges the male and alters her behavior during
pregnancy and lactation, which causes a phenotype in the
offspring. Furthermore, factors present in seminal fluid
Fig. 3 Chronic dexamethasone treatment alters insulin, leptin, and
adiponectin plasma levels and pancreatic islet morphology. a Enzyme-
linked immunosorbent assay (ELISA) measurement at the end of the
dexamethasone treatment showed increases of insulin (p = 0.0044)
and leptin (p = 0.0063) levels as well as a decrease in adiponectin
(p = 0.0374) level. The leptin/adiponectin ratio was increased
(p = 0.0039; n = 15–18). b Assessment of insulin sensitivity by
HOMA-IR showed induction of modest insulin resistance by dexam-
ethasone treatment (p = 0.0159, n = 15–17). c Insulin concentration
during ipGTT is increased by dexamethasone treatment (rANOVA,
p = 0.0474, n = 5–6). Mean ± standard deviation is shown. d Liver
immunohistochemistry shows that liver fat content is increased in
dexamethasone-treated animals. One representative sample is shown
for each group and the scores of all samples analyzed (6 per group) are
given in the table on the right. The higher the score, the more severe is
the fat accumulation (0—none: no lipid staining, 1—mild: single cells
with stained lipid, 2—moderate: patches of cells with stained lipid, and
3—distinct: most cells with stained lipid)
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have been suggested to be potential carriers of intergen-
erational information (Rando 2012). Hence, IVF is para-
mount to truly correlate an observed phenotype in the
offspring to epigenetic alterations present in sperm, as it
excludes both social interaction and seminal fluid as
mechanisms of inheritance. We used sperm of 6 males [3
per treatment group (Veh, Dex)] of the F0 generation to
generate offspring via IVF. Importantly, insulin (1.7-fold)
and leptin (2.1-fold) (data not shown) levels were still
increased to a similar extent at the time of sperm collection
(1 week after the end of dexamethasone treatment) as they
were at the end of the treatment (Fig. 3a). Thus, sperm
used for IVF was exposed to increased insulin and leptin
levels throughout spermatogenesis.
In offspring obtained via IVF, we did not find a difference
due to paternal treatment in body weight at weaning (age of
3 weeks) neither for F1 males (paternal vehicle treatment
(pVeh): 10.4 ± 1.6 g, pDex: 10.8 ± 1.6 g, p = 0.38) nor
for F1 females (pVeh: 10.0 ± 1.8 g, pDex: 10.4 ± 1.7 g,
p = 0.33). Thus, in order to enhance potentially subtle
metabolic phenotypes, we challenged male and female mice
of the F1 generation with a high-fat diet (HFD) starting at
9 weeks of age, a method successfully used in the field
(Fullston et al. 2015).We analyzed the offspring for changes
in body weight gain during the period of HFD challenge
(Fig. 4a) and body composition at the age of 15 weeks
(Figure S2). Male offspring of both paternal treatment
groups weighed on average 26 g at the beginning of the HFD
challenge and gained about 14 g during 6 weeks of HFD. F1
Females weighed around 20 g at the age of 9 weeks in both
groups and gained about 6 g during the 6 week HFD chal-
lenge (Fig. 4a). In contrast to DIO mouse models that
showed increased body weight in the F1 generation due to
paternal HFD (Fullston et al. 2013, 2015), we could not
detect any effect of paternal dexamethasone treatment on
bodyweight at any time. Similarly, themeasurement of body
composition in male and female F1 animals did not provide
evidence for differences depending on paternal treatment
(Figure S2). This again is in contrast to findings in DIO
mouse models that showed increased adiposity due to
paternal HFD (Fullston et al. 2013, 2015).
Most studies focusing on EI of metabolic phenotypes
reported striking alterations in glucose metabolism, espe-
cially in female offspring (Fullston et al. 2013; Ng et al.
2010, 2014; Wei et al. 2014). Accordingly, we measured
fasting blood glucose levels during the HFD challenge
(Fig. 4b) and glucose tolerance at the end of the HFD chal-
lenge in IVF-derived F1 mice (Fig. 4c, d). HFD challenge
increased fasting blood glucose levels in males more dra-
matically than in females; however, we did not detect dif-
ferences in fasting blood glucose levels due to paternal
treatment (Fig. 4b). Alterations in F1 glucose tolerance due
to paternal HFD have been reported in several studies, both
in rat (Ng et al. 2010) and mouse (Fullston et al. 2013; Wei
et al. 2014). We addressed glucose tolerance by ipGTT and
found the expected sex-specific differences with females
beingmore glucose tolerant thanmales (Oliveira et al. 2015);
however, we did not detect any differences in glucose tol-
erance due to paternal dexamethasone treatment (Fig. 4c, d).
Taken together, the data from F1 offspring generated via
IVF did not provide any evidence for EI via sperm, despite
the fact that the changes in insulin and leptin levels in the
dexamethasone-treated fathers are comparable to the
changes in DIO mouse models (Fig. 3a).
Metabolic parameters are unchanged in offspring
from natural matings
To our knowledge, all rodent studies performed thus far on
EI of metabolic phenotypes via the paternal lineage were
carried out by natural mating of dietary-challenged males
with untreated females. Yet, one study on the EI of stress-
related behavioral phenotypes compared offspring con-
ceived by natural mating or IVF and found an inherited
phenotype only if the offspring was conceived naturally,
arguing for inheritance independent from sperm (Dietz
et al. 2011). To test whether the absence of a
detectable metabolic phenotype in the offspring generated
by IVF is due to the lack of social interaction during mating
or lack of factors present in seminal fluid, we also gener-
ated offspring by natural fecundation. A total of 13 males
(6 Veh, 7 Dex) of the F0 generation went into natural
matings and all of them generated offspring. Like for the
IVF experiments described above, in the beginning of the
natural matings (1 week after dexamethasone treatment),
insulin and leptin levels were still in the same range as at
the end of the treatment (Fig. 3a and see above).
Also in the F1 generation from natural matings, we did
not detect differences in weaning weight depending on the
paternal treatment for males (pVeh: 9.7 ± 1.9 g, pDex:
9.8 ± 1.5 g, p = 0.75) and females (pVeh: 9.4 ± 1.5 g,
pDex: 9.4 ± 1.4 g, p = 0.93). At the start of the HFD (age
of 9 weeks), the average body weight was similar in both
groups (males: 23–24 g, females: 18–19 g) and body
weight increased more for males (about 11–12 g) than for
females (about 5–6 g) during the HFD challenge. Again,
we did not detect differences in body weight gain due to
cFig. 4 Paternal dexamethasone treatment does not alter the metabolic
phenotype in the offspring. Offspring conceived either by IVF (a–d;
a, b: n = 22–39, c, d: n = 11–12) or by natural mating (e–h; e, f:
n = 40–61, g, h: n = 14) was fed a HFD starting at 9 weeks of age
(m.: males, f.: females, pVeh: paternal Vehicle, pDex: paternal
Dexamethasone). No differences due to paternal treatment were
observed with respect to body weight gain (a, e), fasting blood
glucose concentration (b, f) or glucose tolerance in an ipGTT (c,
d and g, h). Mean ± standard deviation are shown
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paternal dexamethasone treatment (Fig. 4e). Consistent
with these findings, we did not find evidence for alterations
in body composition due to paternal treatment in the F1
generation from natural matings (Figure S3). As offspring
from natural matings was not generated at a precisely
defined time point (as in IVF) and as the effects induced by
the hormonal changes due to dexamethasone treatment
might be transient, we compared animals with regard to the
round of mating they were sired in. We did, however, not
find any differences in body weight gain dependent on how
long after the treatment they were sired (data not shown).
We did not find difference due to paternal dexamethasone
treatment in fasting blood glucose levels in F1 males and
females during the HFD challenge (Fig. 4f). Also, ipGTTs
did not provide evidence for differences in glucose tolerance
caused by paternal dexamethasone treatment (Fig. 4g, h).
Taken together, also generating offspring via natural
matings did not lead to metabolic differences in offspring
due to paternal dexamethasone treatment. Hence, the
changes in plasma levels of insulin, leptin, and adiponectin
as well as the dexamethasone treatment as such did not lead
to intergenerational inheritance of metabolic phenotypes
such as body weight, body composition, or glucose
tolerance.
Dexamethasone treatment does not alter sperm
transcriptome
Although we did not find phenotypic differences in the F1
generation, we analyzed whether the paternal dexametha-
sone treatment leads to alterations in sperm transcriptomes.
Changes in sperm transcriptomes might provide initial
evidence toward traits other than the metabolic phenotypes
addressed here that could be altered in the offspring.
However, microarray-based transcriptome analyses did not
show any significant change (criteria: FDR\ 10 %,
FC[ 1.2) due to the treatment (the complete transcriptome
data are available from GEO under accession ID
GSE67290). Also, hierarchical cluster (HCL) analysis of
genome-wide expression profiles did not separate the
dexamethasone and vehicle-treated groups (Figure S4).
However, we cannot exclude that other epigenetic changes,
such as miRNAs, DNA methylation, or histone modifica-
tions, could be carriers of information between generations
due to dexamethasone treatment and the accompanying
hormonal alterations.
Discussion
Several studies have reported examples of EI for various
traits in mammals (Heard and Martienssen 2014; Nadeau
2009, 2015; Rando 2012; Rando and Simmons 2015;
Somer and Thummel 2014; Szyf 2015). In particular, an
important role of the paternal diet for the metabolic phe-
notype of the next generation has been established (Carone
et al. 2010; Fullston et al. 2013; Ng et al. 2010, 2014; Wei
et al. 2014). Although these studies did not perform IVF to
unequivocally show inheritance via the gametes, some of
them reported alterations of sperm DNA methylation and
miRNA content (Carone et al. 2010; Fullston et al. 2013;
Ng et al. 2010; Radford et al. 2014; Wei et al. 2014).
Alterations of the sperm epigenome have also been
reported for other environmental factors such as stress
(Dias and Ressler 2014; Rodgers et al. 2013), cocaine
(Vassoler et al. 2013), and the hepatotoxin carbon tetra-
chloride (Zeybel et al. 2012), demonstrating that the sperm
epigenome is receptive for environmental stimuli. One
important step toward understanding EI of MDs is to
decipher the mechanism(s) and specific factors of soma-to-
germline information transfer. Hormones and circulating
RNAs have been suggested as prime candidates for such
factors (Jablonka and Raz 2009; Sharma 2013; Szyf 2015).
Importantly, the data presented in our study demonstrate
that altered plasma levels of insulin, leptin, and adiponectin
in a physiological range that is also observed in DIO mouse
models (Fullston et al. 2013; Ng et al. 2010, 2014; Wei
et al. 2014) are not sufficient for the EI of metabolic
phenotypes, such as body weight, body composition, and
glucose homeostasis, via the paternal lineage even when
the progeny is challenged with a HFD. Moreover, our
mouse model also does not point toward a role for elevated
glucocorticoid levels in EI of altered metabolism across
generations.
MDs such as obesity, MetS, and T2D are characterized
by a number of altered factors besides the hormones ana-
lyzed in our study that could be implicated in EI. Although
our study suggests that altered levels of insulin, leptin, and
adiponectin are not sufficient for soma-to-germline infor-
mation transfer, this does not exclude the possibility that
they—alone or in combination—are required for this
function in conjunction with other factor(s). Further studies
analyzing additional candidate factors in isolation or in
combination with those analyzed here, will be necessary to
identify the factors required and/or sufficient to confer
soma-to-germline information transfer in EI of metabolic
phenotypes.
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